SCHEMBL4434773

SCHEMBL4434773

CC(C)N1CCN(C(Cc2ccccc2)C(=O)O)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.68
CHRM1 P11229 2/20 0.61
HSD17B10 Q99714 3/20 0.55
MAPT P10636 3/20 0.55
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
KDM4E B2RXH2 1/20 0.55
POLB P06746 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
PTPN7 P35236 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NPSR1 Q6W5P4 1/20 0.54
ALDH1A1 P00352 2/20 0.54
PKM P14618 1/20 0.54
HRH3 Q9Y5N1 2/20 0.51
KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515787 0.87 LMNA (0.72) LMNACHRM1HSD17B10MAPTKMT2A
SCHEMBL9277493 0.87 LMNA (0.71) LMNACHRM1HSD17B10MAPTKMT2A
SCHEMBL4143905 0.83 LMNA (0.71) LMNAHSD17B10MAPTKMT2AMEN1
SCHEMBL6420408 0.83 LMNA (0.66) LMNAHSD17B10MAPTKMT2AMEN1
Hydrochloric Acid SCHEMBL9096753 0.82 LMNA (0.69) LMNAHSD17B10MAPTKMT2AMEN1
SCHEMBL6421876 0.81 LMNA (0.64) LMNAHSD17B10MAPTKMT2AMEN1
SCHEMBL4463271 0.81 LMNA (0.68) LMNAHSD17B10MAPTKMT2AMEN1
SCHEMBL19025301 0.81 LMNA (0.68) LMNAHSD17B10MAPTKMT2AMEN1
SCHEMBL7280926 0.81 LMNA (0.68) LMNAHSD17B10MAPTKMT2AMEN1
SCHEMBL9516925 0.81 LMNA (0.68) LMNAHSD17B10MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 US disclosed
US-20050282808-A1 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282808-A1 Benzofuran derivative F12, F2, F11 LMNA 3104/4885CHRM1 2449/4885HSD17B10 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.